Trial Profile
Relapse Rates Among Patients With Multiple Sclerosis Who Switch From Interferon Therapy To Fingolimod Or Glatiramer Acetate: A Retrospective US Claims Database Analysis
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 19 Sep 2014
Price :
$35
*
At a glance
- Drugs Fingolimod (Primary) ; Glatiramer acetate
- Indications Multiple sclerosis
- Focus Therapeutic Use
- Sponsors Novartis
- 19 Sep 2014 New trial record